Arbutus Biopharma (ABUS) EPS (Basic) (2013 - 2026)
Arbutus Biopharma (ABUS) posted EPS (Basic) of $0.88 for Q1 2026, up 3886.96% sequentially from -$0.02 in Q4 2025, and up 780.88% YoY from $0.1 in Q1 2025.
Arbutus Biopharma (ABUS) EPS (Basic) (2013 - 2026) Analysis & Trends
Arbutus Biopharma has reported EPS (Basic) for 14 years, with the latest figure at $0.88 in Q1 2026.
- Quarterly EPS (Basic) rose 780.88% year-over-year to $0.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.83 (up 304.35% YoY) and the FY2025 annual result came in at -$1.12, down 198.55% from the prior year.
- EPS (Basic) rose to $0.88 in Q1 2026 per ABUS's latest filing, from -$0.02 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.88 in Q1 2026 and troughed at -$0.15 in Q4 2022.
- A 5-year average of -$0.03 and a median of -$0.1 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) declined 25.6% in 2025, then surged 780.88% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.15 in 2022, then gained by 19.92% to -$0.12 in 2023, then surged by 39.91% to -$0.07 in 2024, then jumped by 66.93% to -$0.02 in 2025, then soared by 3886.96% to $0.88 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.88, -$0.02, and -$0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03 |
| Mar 31, 2026 | 0.88 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | -0.13 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.11 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | -0.12 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.10 |
| Mar 31, 2022 | -0.11 |
| Dec 31, 2021 | -0.21 |
| Sep 30, 2021 | -0.24 |